Malin Corporation | MLC - Resultado Líquido





Resultado Líquido Alterar Data
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.01M 153K 2026-03
ALKERMES USD 501K 66.98M 2026-06
Avita Medical AUD -11.62M 1.7M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Eurofins Scientific SE EUR 302M 108.3M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Lonza CHF 426M 119M 2025-06
Malin Corporation EUR -1.1M 2.2M 2023-12
Moderna USD -1.34B 517M 2026-03
Organon & Co USD 146M 351M 2026-03
Ovoca Bio EUR -765K 4.89M 2025-06
Revvity USD 40.72M 57.65M 2026-03
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Viatris USD 176.4M 516.5M 2026-03
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03